---
title: "Trump Announces GENEROUS Medicaid Drug-Discount Model; 40 States Reportedly Signed So Far"
id: "stat-news-0-stat-trump-touts-pharma-deals-to-offer-cheaper-drugs-to-state-medicaid-programs"
canonical_url: "https://medichelpline.com/clinical-feed/stat-news-0-stat-trump-touts-pharma-deals-to-offer-cheaper-drugs-to-state-medicaid-programs"
content_type: "clinical_feed_article"
specialty: "Pharmacology"
source_name: "STAT News"
source_url: "https://www.statnews.com/2026/09/18/trump-touts-state-participation-generous-medicaid-drug-discount-program/?utm_campaign=rss"
published_at: "2026-09-18T20:22:36.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Trump Announces GENEROUS Medicaid Drug-Discount Model; 40 States Reportedly Signed So Far
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/stat-news-0-stat-trump-touts-pharma-deals-to-offer-cheaper-drugs-to-state-medicaid-programs
- **Specialty:** [Pharmacology](https://medichelpline.com/clinical-feed/pharmacology.md)
- **Primary Source:** STAT News
- **Source URL:** [Original Journal Publication](https://www.statnews.com/2026/09/18/trump-touts-state-participation-generous-medicaid-drug-discount-program/?utm_campaign=rss)
- **Published At:** 2026-09-18T20:22:36.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- President Trump publicly promoted the **GENEROUS** model, saying all 50 states, Washington, D.C., and Puerto Rico would participate in a program designed to deliver lower drug prices to **Medicaid** programs. - The announcement raised questions because the White House statement and coverage left several details unspecified in the source article. - The Centers for Medicare and Medicaid Services (CMS) reported that 40 states and Puerto Rico had signed agreements to participate; the other jurisdictions had applied and states have until the end of the month to finalize agreements. - The article noted that Trump’s announcement aimed to highlight an administration initiative to reduce drug costs but did not provide further operational details, timelines, drug lists, or projected savings in the published excerpt. - The STAT News story was written by John Wilkerson, dated Sept. 18, 2026, and flagged that additional reporting in the STAT+ paywall continued beyond the accessible excerpt. - The source itself emphasized that many questions about the program remained unanswered in the public announcement and that further specifics were not reported in the accessible portion of the story. - No information in the provided source excerpt described enrollment mechanics for beneficiaries, the financial structure of discounts, enforcement, participating manufacturers, or independent verification of claimed participation beyond the CMS statement. - The accessible content cites CMS as the confirming agency for the participation numbers but notes that full details were available only in the paywalled remainder of the STAT article. - Readers and stakeholders were left without reported data on expected impact, implementation dates, or how GENEROUS would interact with existing Medicaid drug payment rules based on the excerpt. - The piece situates the announcement in Washington reporting and links the subject to policy areas including **drug prices**, HHS, and Medicaid, but does not provide the full STAT+ text in the open excerpt.
## Clinical Analysis & Structured Key Points
[Skip to Main Content](https://www.statnews.com/2026/09/18/trump-touts-state-participation-generous-medicaid-drug-discount-program/?utm_campaign=rss#wrapper) [ ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo-white.svg) ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo.svg) ](https://www.statnews.com/) * [Manage alerts for this article](https://www.statnews.com/my-account/edit/#emails) * [Save this story for later](https://www.statnews.com/my-account/saved/) * [Share this article](https://www.statnews.com/2026/09/18/trump-touts-state-participation-generous-medicaid-drug-discount-program/?utm_campaign=rss) [research](https://www.statnews.com/topic/research/) [RFK Jr.](https://www.statnews.com/topic/rfk-jr/) [HHS](https://www.statnews.com/topic/hhs/) * [Newsletters](https://www.statnews.com/signup/) * [Log In](https://www.statnews.com/login/) * [My Account](https://www.statnews.com/my-account/) * [Subscribe Now](https://www.statnews.com/stat-plus/) My Account * [Settings Complete your personal information for a more tailored experience ](https://www.statnews.com/my-account/) * [Saved Stories](https://www.statnews.com/my-account/saved/) * [Billing](https://www.statnews.com/my-account/billing/) * [Log In](https://www.statnews.com/login/) [ ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo.svg) Reporting from the frontiers of health and medicine ](https://www.statnews.com/) * [Newsletters](https://www.statnews.com/signup/) * [Log In](https://www.statnews.com/login/) * [My Account](https://www.statnews.com/my-account/) * [Subscribe Now](https://www.statnews.com/stat-plus/) * [Biotech](https://www.statnews.com/category/biotech/) * [Pharma](https://www.statnews.com/category/pharma/) * [Public Health](https://www.statnews.com/category/health/) * [Health Tech](https://www.statnews.com/category/health-tech/) * [Policy](https://www.statnews.com/category/politics/) * [Science](https://www.statnews.com/category/in-the-lab/) * [First Opinion](https://www.statnews.com/category/first-opinion/) * [STAT+](https://www.statnews.com/topic/stat-plus/) * [STAT Events](https://www.statnews.com/events/) [ ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo.svg) ](https://www.statnews.com/) Search * [Log In](https://www.statnews.com/login/) * [Subscribe Now](https://www.statnews.com/stat-plus/) * [My Account](https://www.statnews.com/my-account/) My Account * [Settings](https://www.statnews.com/my-account/) * [Saved Stories](https://www.statnews.com/my-account/saved/) * [Billing History](https://www.statnews.com/my-account/billing/) [Home](https://www.statnews.com/) News * [Latest](https://www.statnews.com/latest/) * [Series & Investigations](https://www.statnews.com/stat-series-and-investigations-award-winning-journalism/) * Business * [Biotech](https://www.statnews.com/category/biotech/) * [Pharma](https://www.statnews.com/category/pharma/) * [Health Tech](https://www.statnews.com/category/health-tech/) * [Health Insurance](https://www.statnews.com/category/insurance/) * [Hospitals](https://www.statnews.com/category/hospitals/) * [Medical Devices](https://www.statnews.com/topic/medical-devices/) * Washington * [Policy](https://www.statnews.com/category/politics/) * [FDA](https://www.statnews.com/topic/fda/) * [NIH](https://www.statnews.com/topic/nih/) * Science * [CRISPR](https://www.statnews.com/topic/crispr/) * [Gene Therapy](https://www.statnews.com/topic/gene-therapy/) * [Neuroscience](https://www.statnews.com/topic/neuroscience/) * Public Health * [Addiction](https://www.statnews.com/topic/addiction/) * [Covid-19](https://www.statnews.com/topic/coronavirus/) * [Abortion](https://www.statnews.com/topic/abortion/) * [Health Disparities](https://www.statnews.com/topic/health-disparities/) * [Infectious Disease](https://www.statnews.com/topic/infectious-disease/) * [Mental Health](https://www.statnews.com/topic/mental-health/) * Disease * [Cancer](https://www.statnews.com/topic/cancer/) * [Cardiovascular Disease](https://www.statnews.com/topic/cardiovascular-disease/) * [Chronic Disease](https://www.statnews.com/topic/chronic-disease/) * [Diabetes](https://www.statnews.com/topic/diabetes/) * [Alzheimer's](https://www.statnews.com/topic/alzheimers/) * [Obesity](https://www.statnews.com/topic/obesity/) * Features * [Health Care Costs](https://www.statnews.com/health-insurance-costs-out-of-pocket-out-of-reach-series/) * [The Deadliest Drug](https://www.statnews.com/alcohol-epidemic-hiding-plain-sight-deadliest-drug-series/) * [Science, Shattered](https://www.statnews.com/american-science-shattered/) [Newsletters](https://www.statnews.com/signup/) [Opinion](https://www.statnews.com/category/first-opinion/) Columns * [Adam Feuerstein](https://www.statnews.com/category/adams-take/) * [Matthew Herper](https://www.statnews.com/category/matts-take/) * [Ed Silverman](https://www.statnews.com/category/pharmalot-view/) [Reports](https://reports.statnews.com/) [E-books](https://www.statnews.com/ebooks/) [Podcasts](https://www.statnews.com/podcasts/) [Tools & Trackers](https://www.statnews.com/trackers/) * [CRISPR Tracker](https://www.statnews.com/feature/crispr/tracker/) * [Breakthrough Device Tracker](https://www.statnews.com/feature/stat-plus/breakthrough-device-designation-fda-tracker/) * [Generative AI Tracker](https://www.statnews.com/feature/stat-plus/generative-ai-health-hospitals-tracker/) * [Obesity Drug Tracker](https://www.statnews.com/2023/09/12/new-weight-loss-drug-tracker-novo-nordisk-eli-lilly/) [Events](https://www.statnews.com/events/) * [Upcoming Events](https://www.statnews.com/events#upcoming-events) * [Summits](https://www.statnews.com/stat-summits/) [Community](https://www.statnews.com/community/) * [STAT Wunderkinds 2026](https://www.statnews.com/wunderkinds-nominate/) [Video](https://youtube.com/@Statnews) [Advertise](https://www.statnews.com/advertise/) * [STAT Brand Studio](https://sbs.statnews.com/) What's the word? Test your knowledge with our new weekday mini crossword [ Start solving ](https://www.statnews.com/stat-mini-crossword/) [STAT Plus](https://www.statnews.com/stat-plus/)[Business](https://www.statnews.com/category/business/) # Trump touts pharma deals to offer cheaper drugs to state Medicaid programs ## Every state to participate in GENEROUS model for lower drug prices * [Manage alerts for this article](https://www.statnews.com/my-account/edit/#emails) * [Save this story for later](https://www.statnews.com/my-account/saved/) * [Share this article](https://www.statnews.com/2026/09/18/trump-touts-state-participation-generous-medicaid-drug-discount-program/?utm_campaign=rss) ![](https://www.statnews.com/wp-content/uploads/2026/09/GettyImages-2295966724-645x645.jpg) President Trump speaks to reporters about GENEROUS in the Oval Office at the White House.Chip Somodevilla/Getty Images ![](https://www.statnews.com/wp-content/uploads/2022/11/john-wilkerson-avatar-round-80x80.png) By [John Wilkerson](https://www.statnews.com/staff/john-wilkerson/) Sept. 18, 2026 Washington Correspondent ![](https://www.statnews.com/wp-content/uploads/2022/11/john-wilkerson-avatar-round-80x80.png) [John Wilkerson](https://www.statnews.com/staff/john-wilkerson/) 1. [](https://x.com/john_wilkerson "X") john.wilkerson@statnews.com John writes about the politics of health care, and he is the author of the twice-weekly [D.C. Diagnosis newsletter](https://www.statnews.com/signup/dc/). You can reach John on Signal at John_Wilkerson.07. WASHINGTON — President Trump made an announcement Friday to tout one of his initiatives to lower drug prices. It left many questions unanswered. All 50 states, Washington, D.C., and Puerto Rico will participate in the GENEROUS model, which is intended to give lower drug prices to Medicaid programs, Trump said. Advertisement Later on Friday, the Centers for Medicare and Medicaid Services said that 40 states and Puerto Rico had [signed agreements to participate](https://www.cms.gov/newsroom/press-releases/cms-announces-participants-landmark-medicaid-drug-payment-model-bring-down-drug-costs-most), while the others have applied. States have until the end of the month to sign agreements. [![STAT+](https://www.statnews.com/wp-content/themes/stat/images/stat-plus-logo.svg)](https://www.statnews.com/stat-plus/) To read the rest of this story subscribe to STAT+. [Subscribe](https://www.statnews.com/stat-plus/) [Log In](https://www.statnews.com/login/) [Donald Trump](https://www.statnews.com/topic/donald-trump/), [Drug prices](https://www.statnews.com/topic/drug-prices/), [HHS](https://www.statnews.com/topic/hhs/), [Medicaid](https://www.statnews.com/topic/medicaid/), [Policy](https://www.statnews.com/topic/policy/), [STAT+](https://www.statnews.com/topic/stat-plus/), [White House](https://www.statnews.com/topic/white-house/) [Submit a correction request](https://www.statnews.com/contact/?how_can_we_help_=Editorial%20Correction%20Request)[Reprints](https://www.parsintl.com/publications/stat/) 1. ![](https://www.statnews.com/wp-content/uploads/2022/11/john-wilkerson-avatar-round-80x80.png) [John Wilkerson](https://www.statnews.com/staff/john-wilkerson/) 1. [](https://x.com/john_wilkerson "X") 2. Washington Correspondent 1. [](https://x.com/john_wilkerson "X") 2. John writes about the politics of health care, and he is the author of the twice-weekly [D.C. Diagnosis newsletter](https://www.statnews.com/signup/dc/). You can reach John on Signal at John_Wilkerson.07. ![](https://www.statnews.com/wp-content/themes/stat/images/article-new/envelope-open.svg) ![](https://www.statnews.com/wp-content/uploads/2023/06/DC-Diagnosis-Logo-Black-640x110.png) ### Newsletter The latest updates in federal health agencies, research institutes, and U.S. policy Please enter a valid email address. Sign Up Your data will be processed in accordance with our [Privacy Policy](https://www.statnews.com/privacy/) and [Terms of Service](https://www.statnews.com/terms-conditions/). You may opt out of receiving STAT communications at any time. Advertisement Most Popular 1. ![](https://www.statnews.com/wp-content/uploads/2026/09/Screenshot-2026-09-17-at-12.44.49-PM-80x80.jpg) [Kennedy renews attacks on vaccines at Children’s Health Defense conference](https://www.statnews.com/2026/09/17/rfk-jr-anti-vaccination-activism-childrens-health-defense-conference/) 2. ![](https://www.statnews.com/wp-content/uploads/2026/09/AdobeStock_380169050-80x80.jpeg) [More young men are coming to me for plastic surgery. The way I think about them has changed](https://www.statnews.com/2026/09/18/young-men-plastic-surgery-rates-influencers-lookmaxxing-clavicular/) 3. ![](https://www.statnews.com/wp-content/uploads/2026/09/GettyImages-1732669238-80x80.jpg) [Doctors should educate patients about ‘Asian glow’ and drinking risks](https://www.statnews.com/2026/09/18/what-is-asian-glow-alcohol-flushing-aldh2-drinking-health-consequences/) 4. ![](https://www.statnews.com/wp-content/uploads/2022/04/AP22039367701680-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [A geriatrician explains why AI for older adults deserves careful scrutiny](https://www.statnews.com/2026/09/18/geriatrician-explains-why-ai-for-older-adults-deserves-careful-scrutiny/) 5. ![](https://www.statnews.com/wp-content/uploads/2026/09/Eliza-treated-with-Gene-therapy-2016-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [FDA approves a new gene therapy for Sanfilippo syndrome, an ultra-rare disease](https://www.statnews.com/2026/09/17/sanfilippo-syndrome-treatment-ultragenyx-approval/) #### [ Reports ](https://reports.statnews.com/) [ ![](https://www.statnews.com/wp-content/uploads/2026/08/2026_CancerReport_ReportCover-328x424.jpg) Explore Cancer’s transformational moments: KRAS, CAR-T, immunotherapy, and more ](https://reports.statnews.com/products/cancer-transformational-moments-advances-in-kras-car-t-immunotherapy) Advertisement #### [Events](https://www.statnews.com/events/) [ ![](https://www.statnews.com/wp-content/uploads/2026/07/924_Samsung_VirtualEvent_Wordpress_FeaturedImage-80x80.jpg) Biosimilars: Have We Reached an Inflection Point? Virtual Sep 24 ](https://www.statnews.com/event/biosimilars-what-is-next-virtual-event-sept-2026/) [ ![](https://www.statnews.com/wp-content/uploads/2026/01/Flagship2026_Wordpress_CalendarImageRegGoLive-1-80x80.jpg) 2026 STAT Summit Boston, MA Oct 14 ](https://www.statnews.com/event/2026-stat-summit/) [ ![](https://www.statnews.com/wp-content/uploads/2026/07/2026_DD_OfficeHours_VirtualEvent_Wordpress_CalendarImage-80x80.jpg) Office Hours with Isabella Cueto and Lev Facher Virtual Jul 29 ](https://www.statnews.com/event/deadliest-drug-series-office-hours-ama-july-2026/) Most Read in [STAT+](https://www.statnews.com/stat-plus/) 1. ![](https://www.statnews.com/wp-content/uploads/2025/12/AdobeStock_288008063-80x80.jpeg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Vera kidney drug Trutakna shows strong final results in Phase 3 trial](https://www.statnews.com/2026/09/15/vera-kidney-drug-trutakna-shows-strong-phase-3-results-igan/) 2. ![](https://www.statnews.com/wp-content/uploads/2022/06/AdamsTake_Illustration_MollyFerguson_061322-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [A Sellas immunotherapy study, long delayed, will end in failure](https://www.statnews.com/2026/09/17/sellas-immunotherapy-study-acute-myeloid-leukemia/) 3. ![](https://www.statnews.com/wp-content/uploads/2016/09/Infusion_AP_328963423903-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Scholar Rock wins FDA approval for first drug to target SMA muscle loss](https://www.statnews.com/2026/09/11/scholar-rock-spinal-muscular-atrophy-isembyld-clinical-trial-fda-approval/) 4. ![](https://www.statnews.com/wp-content/uploads/2026/09/Screenshot-2026-09-10-at-11.16.19-AM-e1789064257681-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Novartis, Novo Nordisk drug failures will likely ‘pop a hole in the balloon’ of the field](https://www.statnews.com/2026/09/11/novartis-novo-nordisk-cardiovascular-drug-trials-fallout/) 5. ![](https://www.statnews.com/wp-content/uploads/2025/12/AdobeStock_1649079417-80x80.jpeg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [A biotech hedge fund births a new immunology company ](https://www.statnews.com/2026/09/17/biotech-hedge-fund-startup-north-immunology/) #### Recommended ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) Health Health September 17, 2026 ### [ Kennedy moves to revive preventive services panel with new members, after months of vacancies ](https://www.statnews.com/2026/09/17/kennedy-names-eight-new-members-uspstf-task-force/) By [Chelsea Cirruzzo](https://www.statnews.com/staff/chelsea-cirruzzo/), [Elizabeth Cooney](https://www.statnews.com/staff/elizabeth-cooney/), and [Sarah Todd](https://www.statnews.com/staff/sarah-todd/) ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) Business Business September 16, 2026 ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: GOP aims to change Medicare adviser’s math so it’s more favorable to health insurers ](https://www.statnews.com/2026/09/16/medicare-advantage-overpayments-analysis-medpac-change-apples-to-apples-act/) By [John Wilkerson](https://www.statnews.com/staff/john-wilkerson/) Advertisement ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) Politics Politics September 16, 2026 ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: Senators highlight the power Chris Klomp wields at confirmation hearings ](https://www.statnews.com/2026/09/16/senators-highlight-chris-klomp-power-rfk-jr-second-in-command/) By [Chelsea Cirruzzo](https://www.statnews.com/staff/chelsea-cirruzzo/) ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) In the Lab In the Lab September 14, 2026 ### [ Judge blocks Trump administration plans to limit visa length for grad students, postdocs ](https://www.statnews.com/2026/09/14/court-halts-dhs-visa-limits-foreign-scholars/) By [Jonathan Wosen](https://www.statnews.com/staff/jonathan-wosen/) and [Anil Oza](https://www.statnews.com/staff/anil-oza/) ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) Health Health September 14, 2026 ### [ Kennedy to deliver keynote for anti-vaccine group he once led ](https://www.statnews.com/2026/09/14/rfk-speech-childrens-health-defense-conference-washington/) By [Isabella Cueto](https://www.statnews.com/staff/isabella-cueto/) #### Subscriber Picks 1. ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: Medicare's AI prior authorization pilot was rushed and full of problems, new documents reveal ](https://www.statnews.com/2026/09/15/medicare-wiser-ai-prior-authorization-pilot-rushed-launch-delayed-care/) By [Brittany Trang](https://www.statnews.com/staff/brittany-trang/) 2. ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: FDA approves a new gene therapy for Sanfilippo syndrome, an ultra-rare disease ](https://www.statnews.com/2026/09/17/sanfilippo-syndrome-treatment-ultragenyx-approval/) By [Jason Mast](https://www.statnews.com/staff/jason-mast/) 3. ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: Roivant is one of the savviest dealmakers in biotech. It also has a secret weapon ](https://www.statnews.com/2026/09/10/roivant-biotech-dealmaking-mosliciguat-origins/) By [Adam Feuerstein](https://www.statnews.com/staff/adam-feuerstein/) 4. ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: A biotech hedge fund births a new immunology company ](https://www.statnews.com/2026/09/17/biotech-hedge-fund-startup-north-immunology/) By [Adam Feuerstein](https://www.statnews.com/staff/adam-feuerstein/) 5. ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: A Sellas immunotherapy study, long delayed, will end in failure ](https://www.statnews.com/2026/09/17/sellas-immunotherapy-study-acute-myeloid-leukemia/) By [Adam Feuerstein](https://www.statnews.com/staff/adam-feuerstein/) Share options * [ X ](https://twitter.com/intent/tweet?url=https://www.statnews.com/2026/09/18/trump-touts-state-participation-generous-medicaid-drug-discount-program/&via=statnews&text=Trump%20touts%20pharma%20deals%20to%20offer%20cheaper%20drugs%20to%20state%20Medicaid%20programs "Share on X") * [ Bluesky ](https://bsky.app/intent/compose?text=Trump%20touts%20pharma%20deals%20to%20offer%20cheaper%20drugs%20to%20state%20Medicaid%20programs%20https://www.statnews.com/2026/09/18/trump-touts-state-participation-generous-medicaid-drug-discount-program/%20via%20@statnews.com "Share on Bluesky") * [ LinkedIn ](https://www.linkedin.com/shareArticle?url=https://www.statnews.com/2026/09/18/trump-touts-state-participation-generous-medicaid-drug-discount-program/&mini=true&source=STAT "Linkedin") * [ Facebook ](https://www.facebook.com/sharer/sharer.php?u=https://www.statnews.com/2026/09/18/trump-touts-state-participation-generous-medicaid-drug-discount-program/ "Facebook") * Email * [ Doximity ](https://www.doximity.com/inbox/conversations/new_message?u
## Related Clinical Research

- [Pharmalot job moves: IN8bio hires Oxana Polyakova as senior VP, R&D](https://medichelpline.com/clinical-feed/stat-news-1-stat-up-and-down-the-ladder-the-latest-comings-and-goings.md)
- [U.S. Plans Rules to Preserve Most Pharma Licensing Deals With China, Plus Reports on Post‑Market S](https://medichelpline.com/clinical-feed/stat-news-2-stat-pharmalittle-we-re-reading-about-licensing-deals-with-china-making-drugs.md)
- [Waist circumference predicts mortality more than BMI in adults 65+: study findings](https://medichelpline.com/clinical-feed/medical-news-today-0-bmi-vs-waist-size-study-finds-belly-fat-matters-more-than-weight-for-death-risk.md)
- [Keto Diet Shows Superior Metabolic Benefits Over Mediterranean and Low-Fat Diets](https://medichelpline.com/clinical-feed/medical-news-today-1-keto-diet-may-have-metabolic-advantages-over-mediterranean-low-fat-diets.md)

## Navigation
- [← Back to Pharmacology Feed](https://medichelpline.com/clinical-feed/pharmacology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.